PRESS ROOM
Welcome to the ACE Health AB's Press Room!
Here you will find the latest news, press releases, and media resources pertaining to
ACE Health AB;
Fysiologic - An ACE Company and
Linc AB.
Stay updated on our company announcements, industry insights, and achievements.
For media inquiries, interview requests, or additional information, please contact our media relations team listed below.
We appreciate your interest in all things ACE and look forward to sharing our story with you.
ACE Health AB Acquires Dutch Holter Analysis Company, DGTL Health
ACE Health AB is proud to announce the acquisition of DGTL Health, a leading Dutch company specializing in digital solutions in cardiology.
This acquisition marks a pivotal step in ACE Health's strategic vision to expand its capabilities in advanced cardiac diagnostics and digital healthcare services globall
Streamlining patient care
The acquisition strengthens ACE Health's Holter analysis business, enabling it to offer cutting-edge technology that streamlines patient care, improves diagnostics, and enhances overall healthcare delivery.
DGTL Health's expertise in digital solutions complements ACE Health’s mission to revolutionize the cardiac diagnostic field, further positioning the company as a leader in cardiac diagnostics.
"We are incredibly excited about welcoming DGTL Health into the ACE family.Their proven success in the digital health space aligns perfectly with our vision of delivering efficient and patient-centered cardiac diagnostics. Together, we aim to harness the power of digital transformation to improve patient outcomes and advance the healthcare sector," says Alex Ahlén, CEO of ACE Health AB.
DGTL Health's established partnerships and technological advancements will allow ACE Health to provide even faster, more accurate diagnostics, alleviating the burden on healthcare providers and ensuring better, quicker care for patients with cardiac conditions.
Contact:
Alex Ahlén
CEO
ACE Health AB
alex@acehealth.se
Philip Croon
CEO
DGTL Health
"Over the past years, DGTL Health has developed one of the most technologically advanced Holter analysis platforms on the market. With ACE Health’s acquisition, we are excited that our high-quality, innovative services will now reach a significantly broader patient base. Moreover, this partnership provides us with access to the expertise and resources needed to expand our service offerings, enabling us to better meet the evolving needs of our clients."
says
Philip Croon, CEO of DGTL Health.
ACE Health AB Acquires Europe’s largest ECG analysis company Fysiologic; and welcomes Linc AB as Shareholder
ACE Health AB proudly announces its acquisition of the Dutch company Fysiologic Group B.V.
The acquisition marks a significant step forward in ACE Health’s mission to become a global leader in the cardiac diagnostic field.
In conjunction with this acquisition, Linc AB also becomes a partner and shareholder in ACE Health AB.
This partnership underscores ACE Health AB's commitment to fostering strategic alliances that drive innovation and growth in the healthcare sector.
About
Fysiologic Group B.V.
Fysiologic is a medical technology company specializing in ECG diagnostics and applying all it's knowledge and expertise to detecting arrhythmias.
Fysiologic currently provides ECG solutions in 9 countries on 3 continents analyzing thousands of ECG per day.
Fysiologic has a large team of ECG technicians and cardiologists that follows strict procedures. This guarantees high quality ECG reports.
To ensure the safety and reliability of full-service provision and especially patient privacy, information security is of the utmost importance. Therefore, Fysiologic are ISO 27001 and and NEN 7510 certified.
About Linc
Linc invests in product-oriented companies within the Nordic Life Science industry.
They primarily invest in and develop small to medium-sized product-oriented life science companies within Medical Technology and Pharmaceuticals.
Their investments are made in both private and public
companies, as well as in research and operational companies. Typically, investments in drug development occur at an earlier stage compared to investments in medical technology.
Linc is an active and long-term owner with a broad industrial network to support portfolio companies.
We collaborate with management, founders, and the board to realize the inherent potential within the company, have ambitious plans for further development and expansion, and
actively participate in the nomination committee work.
Joining forces to improve patient outcomes!
Interested in our services? We’re here to help!
We want to know your needs exactly so that we can provide the perfect solution. Let us know what you want and we’ll do our best to help.